Regarding NKG2D, we observed a gradient of expression from lower level (AIDS-RL <300 CD4/mm3) to HS/HIV-negative lymphoma patients, with intermediary levels for AIDS-RL with >0.3 G/L CD4+ lymphocytes followed by HIV + patients without lymphoma. This evidence concerns the gene CD4 and AIDS.